Related Experiment Videos
[Sudden hearing loss. Treatment with piracetam]
J Solanellas Soler1, F Esteban Ortega, L Soldado Patiño
1Servico ORL, Hospital Universitario de Valme, Sevilla.
Acta Otorrinolaringologica Espanola
|January 1, 1997
Summary
Piracetam treatment for sudden hearing loss showed positive results, with 50% of patients experiencing improved hearing. This study explored piracetam
Area of Science:
- Otolaryngology
- Neurology
Context:
- Sudden hearing loss (SHL) is an otologic emergency requiring prompt evaluation.
- Severe to profound hearing loss was observed in all patients.
- Bilateral involvement occurred in 33% of cases.
Purpose:
- To evaluate the efficacy of intravenous piracetam in treating sudden hearing loss.
- To assess the safety and side effects of piracetam treatment for SHL.
Summary:
- Nine patients with severe to profound sudden hearing loss received a 3-day course of intravenous piracetam (10 g/day).
- Audiometric and clinical parameters, including age, sex, and vestibular symptoms, were monitored.
- Post-treatment, 50% of affected ears showed hearing improvement, with no reported side effects.
Impact:
- Intravenous piracetam may be a safe and potentially effective treatment option for sudden hearing loss.
- Further research is warranted to confirm these findings in larger patient cohorts.